FRANKLIN BIOLABS Trademark
FRANKLIN BIOLABS is a USPTO trademark filed by Franklin Biolabs, Inc.. Status: Pending.
Trademark Facts
| Mark | FRANKLIN BIOLABS |
|---|---|
| Serial Number | 99036815 |
| Status | Pending |
| Filing Date | 2025-02-11 |
| Mark Type | Word |
| Nice Classes | 040 (Material Treatment), 042 (Software & IT) |
| Owner | Franklin Biolabs, Inc. |
| Attorney of Record | Victoria D Summerfield |
| Prosecution Events | 13 |
| Latest Event | TROA on 2025-10-20 |
Goods & Services
Pharmaceutical research services; Pharmaceutical drug development and discovery services, namely, providing translational research tools and services for screening, testing, sequencing, and analysis of DNA- and RNA-encoded genetic material for drug candidate development; cell and gene therapy product development services; Analytical services for drug substance and drug product characterization which are for research use and in accordance with Good Manufacturing Practices (GMP); Preclinical services including pharmacology, pharmacokinetics, and toxicology in well established lab animal models; Research and development and Good Laboratory Practices (GLP) services for bioanalytical testing including immunogenicity, biodistribution and shedding to support pre-clinical (animal) and clinical (human) studies; Chemistry, Manufacturing, and Controls (CMC) laboratory and stability testing and analytical services in the fields of therapeutic drug evaluation and development, bioanalytical testing, immunogenicity testing, clinical studies, pre-clinical studies pharmacology, pharmacokinetics, and toxicology; Good Manufacturing Practices (GMP) laboratory and stability testing and analytical services in the fields of therapeutic drug evaluation and development, bioanalytical testing, immunogenicity testing, clinical studies, pre-clinical studies pharmacology, pharmacokinetics, and toxicology; Providing laboratory services for others in accordance with the Clinical Laboratory Improvement Amendments (CLIA) program; Research and development relating to production and analysis of viral-based vectors, pharmaceuticals, biologics, vaccines, biotechnological products, and gene and cell therapy preparations for use in medical research for others; Manufacturing services for others in the fields of viral-based and non-viral vectors, pharmaceuticals, biologics, vaccines, biotechnological products, and gene and cell therapy preparations